MedPath

SurgiBox Secures US Patents for Portable Sterile Surgery Technology

• SurgiBox Inc. has been granted two US patents for its SurgiField™ technology, including an innovative airflow system for clean surgery and a Smart Control Module™ design patent.

• The company's portable surgical system combines an inflatable sterile drape with a battery-powered HEPA filtration system, protected by patents across 20 countries.

• Development of next-generation SurgiField™ technology for extreme environments is underway through strategic partnerships, expanding the potential for mobile surgical care delivery.

Cambridge-based medical device innovator SurgiBox Inc. has secured two crucial United States patents for its revolutionary mobile surgery technology, marking a significant advancement in portable surgical care solutions.
The newly granted patents cover two key innovations: a utility patent for the company's advanced airflow technology enabling clean surgery, and a design patent for their user-friendly Smart Control Module™ featuring single-button automated operation.

Core Technology Innovation

The company's flagship product, SurgiField™, represents a breakthrough in portable surgical technology. It integrates an innovative inflatable sterile drape with an automated, battery-powered HEPA air filtration system, all in an ultraportable design. This technology has already gained patent protection across more than 20 countries, demonstrating its global recognition and potential impact.
Kelly Laurel, MBA, Vice President of SurgiBox and retired US Army Lieutenant Colonel, emphasized the patents' strategic importance: "The patents will aid SurgiBox in commercializing its revolutionary technology in the United States."

Advancing Surgical Care in Extreme Environments

The company is already looking ahead to expand its technological capabilities. Atif Rakin, Chief Technology Officer and Principal Investigator for a Defense Health Agency-funded device project, revealed ongoing development plans: "The US patents will support our next generation of research and development, which will build upon the first SurgiField™ product."
Rakin also disclosed that development of an enhanced version of SurgiField™, specifically designed for deployment in extreme environments, is currently underway with a strategic partner. This next-generation technology aims to further expand the possibilities for mobile surgical care delivery.

Impact on Global Healthcare Access

SurgiBox's innovative technology addresses critical needs in various challenging healthcare settings, including:
  • Austere environments with limited medical infrastructure
  • Disaster zones requiring rapid deployment of surgical capabilities
  • Medical facilities facing substantial surgical backlogs
The portable and self-contained nature of the SurgiField™ system offers a promising solution for bringing sterile surgical capabilities to locations where traditional operating rooms are unavailable or impractical.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

FDA Grants 510(k) Clearance to OrthoNovis's Novel BPS Wrist Fracture System

OrthoNovis has received FDA 510(k) clearance for its BPS Wrist Fracture System, designed for fixation of distal radius fractures, fusions, and osteotomies.
The innovative system aims to provide high-quality orthopedic implants at competitive prices, positioning OrthoNovis to compete in the growing US orthopedic fracture fixation market.

FDA Grants Breakthrough Device Designation to Averto Medical's ColoSeal System for Ostomy-Free Colorectal Surgery

Averto Medical's ColoSeal Intraluminal Colonic Diversion System has received FDA Breakthrough Device Designation, offering a potential alternative to temporary ostomies in colorectal surgery.
The company secured $30.5 million in Series A funding led by Cormorant Asset Management and received a $1.8 million NCI grant to advance clinical testing of the innovative device.

FDA Greenlights Phase 2 Trial of TPX-115 Cell Therapy for Rotator Cuff Tears

Tego Science receives FDA approval for Phase 2 clinical trial of TPX-115, an allogeneic dermal-derived fibroblast therapy for rotator cuff partial tears.
The randomized, double-blind study will enroll 60 patients with Ellman grade 2 partial thickness rotator cuff tears across multiple U.S. medical institutions.

Envoy Medical Expands Patent Portfolio with Advanced Cochlear Implant Technologies

Envoy Medical secures five new patents across US, Japanese, and Hong Kong jurisdictions for innovative cochlear implant technologies, strengthening their intellectual property portfolio in hearing health solutions.
The US patents focus on breakthrough inner ear sensor technology and adjustable stereo cochlear implant systems, advancing the development of their fully implanted Acclaim Cochlear Implant.

OrthoPreserve's Meniscus Implant, Defender, Receives FDA Breakthrough Device Designation and TAP Enrollment

OrthoPreserve's Defender implant received FDA Breakthrough Device Designation and TAP enrollment for treating post-meniscectomy knee pain and impairment.
The implant addresses a significant treatment gap for patients who experience poor outcomes after standard meniscus surgeries, potentially delaying or preventing knee replacements.

Aduro Clean Technologies Patents Novel Process Design for Plastic Recycling Technology

Aduro Clean Technologies has filed a U.S. patent application for an innovative process design that integrates standard industrial equipment with their Hydrochemolytic™ Technology for efficient plastic recycling.
The new design enables effective deconstruction of various polymers including polyethylene, polypropylene, and polystyrene, marking a significant advancement in chemical recycling scalability.

Axcynsis Therapeutics' AT03-65 Receives FDA IND Clearance for CLDN6-Targeting ADC

Axcynsis Therapeutics received FDA clearance for its IND application for AT03-65, a differentiated CLDN6-targeting antibody-drug conjugate (ADC).
AT03-65 leverages Axcynsis' AxcynDOT™ technology for precise drug delivery to tumors expressing CLDN6, a target in various cancers.

Prokarium Secures Two US Patents for Novel Cancer Immunotherapy Platform

Prokarium has received two USPTO Notices of Allowance strengthening its position in bladder cancer treatment, covering salmonella-based immunotherapy and combination therapy with checkpoint inhibitors.
The company's lead candidate ZH9, an intravesical immunotherapy for non-muscle invasive bladder cancer, is currently enrolling patients in the PARADIGM-1 study across multiple US centers.

SpineGuard's PsiFGuard Receives FDA Clearance for Sacroiliac Joint Fusion

SpineGuard's PsiFGuard, a smart drilling device for posterior sacroiliac fusion (PsiF), has received FDA 510(k) clearance for commercial use in the United States.
The PsiFGuard device utilizes SpineGuard's Dynamic Surgical Guidance (DSG®) technology to enhance the accuracy of implant placement in SI joint fusion procedures.

Innovations and Trials in Medical Technology

Recent advancements in medical technology include the launch of the CrossWise RF transseptal access system by Circa Scientific, completion of enrollment in a pivotal trial for Inquis Medical's Aventus thrombectomy system, a distribution agreement between Medtronic and Contego Medical, a $12 million Series A round for Relief Cardiovascular, CE mark approval for Johnson & Johnson MedTech's dual-energy catheter, a temporary pause on Varipulse PFA system cases by Johnson & Johnson MedTech, and the completion of a first-in-human study by AerWave for its lung denervation therapy.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy